Variability in fibrinogen measurements: An obstacle to cardiovascular risk stratification

Atherosclerosis

Volumn 159, Issue 1, 2001, Pages 225-230

  Rosenson, Robert S ^a,c   Mosca, Lori ^b   Staffileno, Beth A ^a   Tangney, Christine C ^a  

^a Preventive Cardiology Center   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Fibrinogen; Risk factors; Thrombosis

Indexed keywords

FIBRINOGEN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FIBRINOGEN BLOOD LEVEL; FUNCTIONAL ASSESSMENT; HUMAN; MALE; MEASUREMENT; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0034751022     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00503-2     Document Type: Article

References (40)

1. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature
2. Fibrinogen as a risk factor for stroke and myocardial infarction
3. Plasma fibrinogen: A major coronary risk factor
4. Haemostatic function and ischemic heart disease: Principal results of the Northwick Park Heart Study
5. Fibrinogen and risk of cardiovascular disease: The Framingham Study
6. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease
7. Fibrinogen and factor VII in the prediction of coronary risk: Results from the PROCAM study in healthy men
8. 21 Year followup of CVD and total mortality among men born in 1913
9. Fibrinogen, viscosity and the 10 year incidence of ischaemic heart disease. The Caerphilly and Speedwell Studies
10. Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: Results from the prospective Gottingen risk incidence and prevalence study (GRIPS)
11. Coagulation factor VII and the risk of coronary heart disease in healthy men
12. Prospective study of hemostatic factors and incidence of coronary heart disease: The atherosclerosis risk in communities (ARIC) study
13. Fibrinogen and factor VII activity as risk factors for cardiovascular disease in an elderly cohort
14. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham offspring population
15. Crosslinked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease
16. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study
17. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
18. Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris
19. For the Bezafibrate Infarction Prevention (BIP) Study Group: Fibrinogen is a predictor of mortality in coronary heart disease patients
20. A 6 year prospective study of fibrinogen and other risk factors associated with mortality in stable claudicants
21. Influence of platelet size on outcome after myocardial infarction
22. Fibrinogen and other clotting factors in cardiovascular disease
23. Intraindividual variability of fibrinogen levels and cardiovascular risk profile
24. Quick method to estimate fibrinogen by a functional clotting assay
25. Effects of tourniquet technique, order of draw, and sample storage on plasma fibrinogen
26. Myocardial injury, acute phase response and lipoprotein metabolism
27. Blood pressure, stroke, and coronary heart disease
28. Identifying adults at increased risk of coronary disease: How well do the current cholesterol guidelines work?
29. Analytical and biologic variability in measures of hemostasis, fibrinolysis, and inflammation: Assessment and implications for epidemiology
30. Short-term intraindividual variability in hemostasis factors. The ARIC study
31. Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris
32. Intra-individual variability of fibrinogen levels
33. Seasonal variations of rheological and hemostatic parameters and acute-phase reactants in young, healthy subjects
34. Seasonal variations in fibrinogen concentrations among elderly people
35. The variability of and associations between measures of blood coagulation, fibrinolysis and blood lipids
36. Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: Winter infections and death from cardiovascular disease
37. ARIC hemostasis study - IV. Intraindividual variability and reliability of hemostatic factors
38. Sources of variability in coagulation factor assays
39. Determinants of plasma fibrinogen: Relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex: Results from the Second MONICA Augsburg Survey. 1989-1990
40. Retest reliability for plasma cholesterol and triglyceride. The Lipid Clinics Prevalence Study